What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.11%Below 5Y avg (1.98%)
Annual Rate
CNY 0.05Paid annual
Payout Ratio
64.0%Moderate
Payback Period
91.0 yr
Last Ex-Dividend
May 28, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.40BCNY
504.28M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
29.13x
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Revenue (TTM)
1.73BCNY
256.27M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
6.31%
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Beta
0.2140x
vs all stocks
Updated Aug 20, 2026
52-Week Change
-21.56%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
3.40BCNY
504.28M · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
4.74BCNY
703.51M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
29.13x
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
PEG Ratio
-0.6658x
Updated Aug 20, 2026
Price to Sales (TTM)
2.03x
vs Pollution & Treatment Controls peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 1.97×.Updated Aug 20, 2026
Price to Book (MRQ)
0.7777x
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Enterprise to Revenue
2.75x
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Enterprise to EBITDA
11.52x
vs Pollution & Treatment Controls peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 12.51×.Updated Aug 20, 2026
Gross Margin
39.95%
vs Pollution & Treatment Controls peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 35.6%.Updated Aug 20, 2026
Profit Margin
6.31%
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Operating Margin
30.90%
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Return on Assets (TTM)
2.29%
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Return on Equity (TTM)
2.56%
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Revenue (TTM)
1.73BCNY
256.27M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
2.40CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
24.70%
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Gross Profit (TTM)
614.32MCNY
91.24M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
378.67MCNY
56.24M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
108.89MCNY
16.17M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
-45.80%
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
282.18MCNY
41.91M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
289.15MCNY
42.94M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing Annual Dividend Rate
0.0500CNYUpdated Aug 20, 2026
Trailing Annual Dividend Yield
1.11%
vs all stocks
Updated Aug 20, 2026
5-Year Average Dividend Yield
1.98%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
63.98%
vs Pollution & Treatment Controls peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 31.25%.Updated Aug 20, 2026
Minority Interest (Equity)
131.10MCNYFY2025 · Dec 31, 2025
Revenue
1.66BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.07BCNYFY2025 · Dec 31, 2025
Gross Profit
583.68MCNYFY2025 · Dec 31, 2025
Operating Income
357.81MCNY
53.14M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
236.65MCNYFY2025 · Dec 31, 2025
Income Tax Expense
64.52MCNYFY2025 · Dec 31, 2025
Net Income
172.14MCNYFY2025 · Dec 31, 2025
EBIT
324.45MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
470.53MCNYFY2025 · Dec 31, 2025
Research & Development
28.63MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
70.36MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
14.72MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
499.18KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
87.80MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.2343CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.2343CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
727.13MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
727.13MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
172.14MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-1.77MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
134.55MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-84.84MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
247.50MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
172.14MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
91.09MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-149.51MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
20.84MCNYFY2025 · Dec 31, 2025
Capital Expenditures
219.39MCNYFY2025 · Dec 31, 2025
Net Acquisitions
11.68MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-72.41MCNYFY2025 · Dec 31, 2025
Sale of Investments
29.70MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
188.36MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
673.12MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-848.94MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-140.27MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-27.52MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-343.62MCNYFY2025 · Dec 31, 2025
Shares Outstanding
756.26MSharesUpdated Aug 20, 2026
Float Shares
489.82MSharesUpdated Aug 20, 2026
% Held by Insiders
32.40%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
0.64%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
400.97MCNY
59.55M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
0.5500CNYUpdated Aug 20, 2026
Total Debt (MRQ)
1.61BCNY
238.71M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.3570x
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Current Ratio (MRQ)
1.53x
vs Pollution & Treatment Controls peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
5.99CNYUpdated Aug 20, 2026
Total Assets
7.94BCNY
1.18B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
3.39BCNYFY2025 · Dec 31, 2025
Total Liabilities
3.52BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
4.55BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.08BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
2.44BCNYFY2025 · Dec 31, 2025
Cash
248.48MCNYFY2025 · Dec 31, 2025
Cash Equivalents
21.47MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
269.95MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
98.51MCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.75BCNYFY2025 · Dec 31, 2025
Inventory
156.30MCNYFY2025 · Dec 31, 2025
Accounts Payable
1.28BCNYFY2025 · Dec 31, 2025
Short-term Debt
808.72MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
79.27MCNYFY2025 · Dec 31, 2025
Long-term Debt
752.61MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
227.03MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
756.26MCNYFY2025 · Dec 31, 2025
Retained Earnings
2.41BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
4.43BCNY
657.44M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
169.86MCNYFY2025 · Dec 31, 2025
52-Week Low
4.11CNYUpdated Aug 20, 2026
52-Week High
6.56CNYUpdated Aug 20, 2026
52-Week Change
-21.56%
vs all stocks
Updated Aug 20, 2026
Beta
0.2140x
vs all stocks
Updated Aug 20, 2026
50-Day MA
4.53CNYUpdated Aug 20, 2026
200-Day MA
5.40CNYUpdated Aug 20, 2026
Avg 10-Day Volume
7.66MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
9.18MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
0.1600CNYUpdated Aug 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 30.9%, higher than 95% of its Pollution & Treatment Controls peers (median 8.1%)Significant